Search PubMed⌕ Search

Biomedical subjects

C Stellbrink

Publications and source records attributed to C Stellbrink.

At least 55 records · Page 3Linked to original sources
PubMed1999

The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study.

In conjunction with pharmacologic therapy, pacing has been proposed as a potential treatment to decrease symptoms in patients with moderate-to-severe congestive heart failure (CHF). Uncontrolled studies of pacing therapy for CHF dealing with different pacing sites, modes of pacing, and atrioventricular delays have reported mixed outcomes. The Pacing Therapies in Congestive Heart Failure (PATH-CHF) study is a single-blind, randomized, crossover, controlled trial designed to evaluate the effects of pacing on acute hemodynamic function and to assess chronic clinical benefit in patients with moderate-to-severe CHF. The effect of pacing on oxygen consumption at peak exercise and at anaerobic threshold during cardiopulmonary exercise tests, and on 6-minute walk distance, have been selected as primary endpoints of the study. Secondary endpoints of the trial were changes in New York Heart Association (NYHA) functional class, quality-of-life as assessed by the Minnesota Living with Heart Failure questionnaire, and hospitalization frequency. Finally, changes in ejection fraction, cardiac output, and filling pattern were assessed by echocardiography. The trial was planned to include 53 patients from 7 centers in Europe over a period of 3 years. The study was divided into 2 parts: acute testing and chronic follow-up. The acute study, performed during the pacemaker implantation, involved extensive testing using a custom-designed computer (FLEXSTIM) and a unique burst pacing protocol (FLEXSTIM protocol) to determine the best ventricular pacing sites and the most appropriate atrioventricular delays. The chronic phase consisted of a crossover study designed to test in each patient the best univentricular pacing site and biventricular pacing as assessed by the acute hemodynamic study. The study started with the first implant in 1995 and has, to date, included 42 patients. The study is expected to be completed by the end of 1998. The results of a first interim analysis showed trends toward improvement in all primary and secondary endpoints during the pacing periods compared with no pacing.

Adult↗
PubMed1999

Transvenous biventricular pacing for heart failure: can the obstacles be overcome?

Despite increasing evidence of hemodynamic benefit and long-term improvement in clinical status of congestive heart failure (CHF) patients with left ventricular and biventricular pacing, the risks and technical limitations of placing a permanent left ventricular pacing lead have prevented widespread clinical adoption of this therapy. Results of this and other recent investigations suggest it is necessary to target specific sites on the left ventricle to maximize hemodynamic benefit. However, limitations and variations of coronary vein anatomy, as well as patient safety, lead dislodgement, pacing thresholds, lead handling, and ease-of-use issues, present technical challenges for current transvenous permanent pacing lead designs. However, a new transvenous lead system based on an over-the-wire design appears to solve many of these problems and has proved feasible in acute clinical studies.

Animals↗
PubMed1999

Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia.

Treatment of congestive heart failure (CHF) aims for symptomatic relief and reduction of mortality both from sudden death and pump failure. The implantable cardioverter defibrillator (ICD) is highly effective in the prevention of sudden death, but no mortality benefit in advanced CHF has yet been shown. Biventricular pacing may lead to functional improvement in selected patients with CHF. Thus, a biventricular pacemaker with defibrillation capabilities may be ideal for patients with advanced CHF. We retrospectively analyzed the data from 384 patients (age 59 +/- 12 years, 322 male and 62 female) with regard to New York Heart Association (NYHA) CHF class, mean QRS duration, mean PR interval, presence of a QRS > 120 msec and incidence of atrial fibrillation at the time of ICD implantation. Based on eligibility criteria from studies in biventricular pacing, we analyzed how many patients may benefit from biventricular pacing. Patients with CHF were older (NYHA class III: 60.9 +/- 9.7, class II: 61.3 +/- 10 versus class I: 50.8 +/- 13.6 years, p < 0.001 each) and mean QRS duration was longer with advanced CHF (NYHA class III 127.8 +/- 30 msec; class II 119.4 +/- 27.7 msec; class 0-1: 103.9 +/- 17.7 msec, p < 0.001, analysis of variance) as was the mean PR interval (NYHA class III 189.9 +/- 33.5 msec; class II 176.1 +/- 29.3 msec; class 0-1 162.7 +/- 45.9 msec, p < 0.001, analysis of variance). The incidence of atrial fibrillation was higher in class III (25.5%) compared with class 0-1 (16.9%) and class II patients (14.1%, p = 0.043, chi-square test). A total of 28 patients (7.3%) fulfilled eligibility criteria for biventricular pacing if NYHA class III patients were considered candidates and 48 (12.5%) if patients with NYHA II CHF and ejection fraction < or = 30% were included. Thus, biventricular pacing may offer a promising therapeutic approach for a significant proportion of patients with CHF at risk for ventricular tachyarrhythmia.

Aged↗
PubMed1999

Optimized pulse durations minimize the effect of polarity reversal on defibrillation efficacy with biphasic shocks.

There are conflicting results on the effect of polarity change on the defibrillation efficacy of biphasic shocks possibly caused by different shock durations. The goal of the present study was to investigate the influence of polarity reversal on defibrillation efficacy for different biphasic shock durations in a porcine animal model. In eight anesthesized pigs using a transvenous/submuscular lead system DFTs for 4 phase 1 durations were determined: 8.1 ms, 6 ms, 3.8 ms and 1.7 ms. The phase 1/phase 2 ratio was constant at 60%/40%. For cathodal shocks, the defibrillation coil in the right ventricular apex was the cathode during phase 1 and for anodal shocks it was the anode. For both polarities, the strength-duration curve revealed a DFT minimum at 3.8 ms (cathodal shocks: 21.3 +/- 6.4 J, P < 0.001; anodal shocks: 21.9 +/- 8 J, P = 0.05). For anodal shocks and phase 1 durations of 1.7, 3.8, and 6 ms there was no significant difference of the stored energy at the DFT compared to cathodal shocks. In contrast, significantly lower DFTs were observed for anodal shocks with a phase 1 duration of 8.1 ms (28.8 +/- 6.4 J compared to 33.1 +/- 5.9 J for cathodal shocks, P = 0.006). The effect of lower defibrillation energy requirements with polarity reversal depends on the total biphasic shock duration; for the pulse duration with the lowest DFT, polarity reversal does not increase defibrillation efficacy of biphasic shocks.

Animals↗
PubMed1998

Influence of phase duration of biphasic waveforms on defibrillation energy requirements with a 70-microF capacitance.

BACKGROUND: Phase duration of biphasic shocks may be an important determinant of defibrillation success. The purpose of this study was to investigate the effect of changing phase duration of biphasic pulses delivered by 70-microF capacitors on defibrillation energy requirements. This may be clinically relevant for the optimization of implantable cardioverter-defibrillator design and programming. METHODS AND RESULTS: Defibrillation thresholds (DFTs) were determined for 13 waveforms in 13 pigs by application of a 70-microF capacitance and a transvenous/submuscular lead system. In part I, phase-1 duration varied, preserving a phase-1/phase-2 duration ratio of 60%/40%. The phase-1 durations were 1, 2, 3, 4, 5, and 6 ms. The DFT was lowest (22.9+/-7 J) for phase 1=3 ms compared with phase 1=1 ms (36.4+/-7.5 J), 2 ms (25+/-6.5 J), 4 ms (25+/-7.6 J), 5 ms (30.7+/-7.3 J), or 6 ms (32.9+/-8.1 J) (P<.001). In part II, phase-1 duration was 3 ms but phase-2 duration varied: 0.7, 1.3, 2, 2.7, 3.3, 4, and 6 ms. Significant DFT minima were found at phase 2=2 ms (22.5+/-4.2 J) and phase 2=4 ms (22.5+/-4.2 J) compared with phase 2=0.7 ms (31.7+/-9.3 J), phase 2=3.3 ms (26.7+/-6.1 J), or phase 2=6 ms (28.3+/-6.8 J) (P<.05). CONCLUSIONS: The strength-duration curve of biphasic defibrillation shocks demonstrates a single optimum for phase-1 duration. In contrast, two optima with minimal energy requirements were found for phase-2 duration. Optimization of both phases of low-capacitance biphasic shocks may reduce energy requirements for defibrillation.

Animals↗
PubMed1998

[Value of spiro-ergometry and stress echocardiography on optimized programming of the upper frequency limit of dual chamber cardiac pacemakers].

Patients with a dual chamber pacemaker often suffer from chronic heart failure. The influence of the upper tracking rate on cardiac performance in patients with and without congestive heart failure is unknown. Therefore, twenty patients with a dual chamber pacemaker implanted for high degree AV block were randomly programmed to upper tracking rates of 110, 120, and 130 bpm. Oxygen uptake (VO2), work capacity, and heart rate were determined at the anaerobic threshold (AT) and at peak exercise using spiroergometry every 4 weeks. Nine patients (71 +/- 12 years) had evidence for advanced heart failure (Weber C/D, group I); 11 patients (60 +/- 6 years) had no or only mild heart failure (Weber A/B, group II). Patients in group II achieved a higher mean VO2-AT at 130 bpm (17.3 +/- 3.9 ml/min/kg) than at 110 bpm (13.7 +/- 4.0 ml/min/kg; p = 0.001). Maximum oxygen uptake and work capacity at the anaerobic threshold were also significantly higher in group II with an upper tracking rate of 130 bpm than at 110 bpm (20.5 +/- 4.5 ml/min/kg vs. 18.2 +/- 5.3 ml/min/kg, p = 0.031, and 98 +/- 29 W vs. 86 +/- 27 W, p = 0.04). In group I, mean oxygen uptake at the anaerobic threshold (VO2-AT) was higher at 110 bpm (11.1 +/- 4.0 ml/min/kg) than at 130 bpm, although of only borderline statistical significance (9.2 +/- 2.6 ml/min/kg; p = 0.052). In group I a higher upper rate decreased VO2-AT by 24%, whereas in group II the higher upper rate improved aerobic capacity by 26%. Stressechocardiography (VVI pacing with a maximum tracking rate of 130 bpm) revealed new wall motion abnormalities in all patients of group I, but only in one patient of group II. Wall motion score index increased from 1.20 +/- 0.24 at rest to 1.54 +/- 0.28 under stress (p < 0.001) in group I, but not in group II (1.00 +/- 0 vs. 1.06 +/- 0.19; p = n.s.). Thus, carriers of dual-chamber pacemakers with no or mild heart failure (Weber A/B) benefit from higher programmed upper rates. In contrast, patients with more advanced heart failure (Weber C/D) improve aerobic capacity with lower programmed upper rates. This may be caused by exercise-induced ischemia in group I as indicated by stressechocardiography.

Aged↗
PubMed1998

Influence of polarity reversal on defibrillation success with biphasic shocks and a transvenous/subcutaneous defibrillator system in a porcine animal model.

Clinical studies show that polarity reversal affects defibrillation success in transvenous monophasic defibrillators. Current devices use biphasic shocks for defibrillation. We investigated in a porcine animal model whether polarity reversal influences defibrillation success with biphasic shocks. In nine anesthetized, ventilated pigs, the defibrillation efficacy of biphasic shocks (14.3 ms and 10.8 ms pulse duration) with "initial polarity" (IP, distal electrode = cathode) and "reversed polarity" (RP, distal electrode = anode) delivered via a transvenous/subcutaneous lead system was compared. Voltage and current of each defibrillating pulse were recorded on an oscilloscope and impedance calculated as voltage divided by current. Cumulative defibrillation success was significantly higher for RP than for IP for both pulse durations (55% vs 44%, P = 0.019) for 14.3 ms (57% vs 45%, P < 0.05) and insignificantly higher for 10.8 ms (52% vs 42%, P = ns). Impedance was significantly lower with RP at the trailing edge of pulse 1 (IP: 44 +/- 8.4 vs RP: 37 +/- 9.3 with 14.3 ms, P < 0.001 and IP: 44 +/- 6.2 vs RP: 41 +/- 7.6 omega with 10.8 ms, P < 0.001) and the leading edge of pulse 2 (IP: 37 +/- 5 vs RP: 35 +/- 4.2 omega with 14.3 ms, P = 0.05 and IP: 37.5 +/- 3.7 vs RP: 36 +/- 5 omega with 10.8 ms, P = 0.02). In conclusion, in this animal model, internal defibrillation using the distal coil as anode results in higher defibrillation efficacy than using the distal coil as cathode. Calculated impedances show different courses throughout the shock pulses suggesting differences in current flow during the shock.

Animals↗
PubMed1998

Influence of body position on defibrillation thresholds of nonthoracotomy implantable defibrillators: a prospective randomized evaluation.

INTRODUCTION: Defibrillation thresholds (DFTs) usually are determined with the patient in the supine position. However, patients may be in the upright position when a shock is delivered during follow-up, which may explain some first shock failures observed clinically. This study investigated whether body posture affects defibrillation energy requirements of nonthoracotomy implantable cardioverter defibrillators with biphasic shocks. METHODS AND RESULTS: Using a step up-down protocol, DFTs were compared intraindividually in 52 patients ("active-can" sytems in 41 patients, two-lead systems in 11 patients) for the supine and upright positions as achieved by a tilt table. The mean DFT was 7.3 +/- 4.2 J in the supine versus 9.2 +/- 4.8 J in the upright position (P = 0.002). Repeated comparison in reversed order 3 months after implantation in 22 patients revealed thresholds of 6.2 +/- 2.5 J (supine) versus 8.4 +/- 3.7 J (upright; P < 0.03) 1 week and 4.4 +/- 2.4 J (supine) versus 6.2 +/- 4.1 J (upright; P < 0.04) 3 months after implantation. DFTs decreased significantly for both body positions from 1 week to 3 months after implantation (P < 0.04). CONCLUSION: (1) DFTs for biphasic shocks delivered by nonthoracotomy defibrillators are higher in the upright compared to the supine body position. (2) Differences remain significant 3 months after implantation. For both body positions, DFT decreases significantly from 1 week to 3 months after implantation. These findings have important implications for programming first shock energy to lower than maximal values or for development of devices with lower maximal stored energy.

Defibrillators, Implantable↗
PubMed1997

[Importance of endocardial ECG for successful AV-node modulation in patients with AV-node reentry tachycardia].

UNLABELLED: In 49 patients undergoing slow pathway (SP) ablation for AV nodal reentrant tachycardia (AVNRT) the local electrograms of successful and non-successful radiofrequency current applications taken from the mapping/ablation catheter in the posteroseptal space were retrospectively analyzed with respect to the following parameters: 1) ratio of local atrial (A) to local ventricular (V) electrogram amplitude (A/V-ratio), 2) presence of fractionated atrial activity (FAA) or SP potential (SPP), 3) duration of local A electrogram. Ablation sites were classified in 3 groups: group I: no FAA/SPP, A/V-ratio > or = 0.25; group 2: FAA/SPP or A/V-ratio < 0.25; group 3: FAA/SPP and A/V-ratio < 0.25. RESULTS: In all patients SP ablation was successful after 4.6 +/- 4.4 applications. Successful ablation sites had a significantly smaller A/V-ratio than non-successful ones (0.2 +/- 0.04 vs. 0.44 +/- 0.06, p = 0.023). The local A electrogram duration was not significantly different (72.3 +/- 2.14 vs. 71 +/- 1.35 ms, p = n. s.). CONCLUSIONS: 1) In SP ablation of AVNRT the local A/V-ratio is significantly smaller in successful compared to non-successful ablation sites. 2) Local A electrogram duration does not correlate with ablation success. 3) A local A/V-ratio of < 0.25 and the presence of a SPP or FAA are correlated with ablation success.

Adult↗
PubMed1997

A prospective, randomized comparison of temperature-controlled vs manually delivered radiofrequency catheter ablation in patients undergoing atrioventricular nodal modification or accessory pathway ablation.

AIMS: In a prospective, randomized study, the effect of temperature control on radiofrequency catheter ablation was compared in 69 patients undergoing atrioventricular nodal modification (n = 32) or ablation of an accessory pathway (n = 37). METHODS AND RESULTS: Thirty-five patients were randomized to temperature control, 34 to manually delivered radiofrequency ablation. The success rate was 92.5% for accessory pathway ablation and 100% for atrioventricular nodal modification. Mapping duration was significantly reduced only in patients undergoing atrioventricular nodal modification. The number of applications was higher for manually delivered ablation in patients undergoing atrioventricular nodal modification (5.6 +/- 1.1 vs 1.9 +/- 0.4, P = 0.004) as was the cumulative energy delivered (5034 +/- 1008 vs 2054 +/- 517 W, P = 0.013) whereas the mean power per application was higher with temperature control (41.4 +/- 1.8 vs 34.1 +/- 1.1 W, P = 0.002). No significant differences in these parameters were found in patients undergoing accessory pathway ablation. Coagulum formation on the catheter tip was observed more often with manually delivered ablation 5.3% vs 0.9%, P = 0.026). The success rate with the initially randomized application mode was higher for temperature control (94.3 vs 61.8%, P = 0.003). CONCLUSIONS: Temperature control during radiofrequency current ablation significantly reduces mapping duration, necessary applications and cumulative energy in atrioventricular nodal modification, but not accessory pathway ablation. Coagulum formation on the catheter tip still occurs but is significantly reduced compared to manually delivered radiofrequency current.

Atrioventricular Node↗
PubMed1997

Polarity reversal improves defibrillation efficacy in patients undergoing transvenous cardioverter defibrillator implantation with biphasic shocks.

The purpose of this study was to determine the influence of polarity reversal on DFT in patients undergoing implantation of nonthoracotomy defibrillators with biphasic shocks. Previous studies have shown higher defibrillation efficacy with using the distal electrode as anode implantation of nonthoracotomy defibrillators and monophasic shocks. However, it is as yet unclear whether biphasic shock defibrillation will also be influenced by polarity reversal. Using a transvenous lead system with a proximal electrode in the superior caval vein and a distal electrode in the RV apex, 27 patients undergoing defibrillator implantation were randomized to DFT testing "initial" (distal electrode = cathode) or "reversed" polarity (distal electrode = anode). Defibrillation energy was reduced stepwise until defibrillation failure occurred. At this point, polarity was switched and testing continued until the lowest energy requirement was determined for both polarities. With reversed polarity, DFT was 11.1 +/- 5.7 J versus 13.3 +/- 5.8 J with polarity (P = 0.033). This means a 17% reduction of the DFT. In 10 patients, the threshold was lower with reversed, whereas in 3 patients it was lower with initial polarity. In conclusion, changing electrode polarity in transvenous implantable defibrillators with biphasic shocks may significantly influence defibrillation energy requirements. Therefore, polarity reversal should always be attempted before considering patch implantation.

Adult↗
PubMed1997

Transcoronary venous radiofrequency catheter ablation of ventricular tachycardia.

Ventricular tachycardias in coronary artery disease arise mostly from endocardial sites. However, little is known about the site of origin in other diseases. We present the case of an incessant, adenosine-sensitive ventricular tachycardia arising from the lateral wall of the left ventricle in a patient with mildly reduced left ventricular function. Intracardiac mapping suggested an epicardial origin, and the tachycardia was successfully ablated from a coronary sinus branch. After ablation, left ventricular function returned to normal. Transcoronary venous radiofrequency catheter ablation is a new approach for the treatment of ventricular tachycardia. Its value in the management of other types of ventricular tachycardia has yet to be determined.

Adult↗
PubMed1995

Preexcitation in hypertrophic cardiomyopathy: a case of a fasciculoventricular Mahaim fiber.

A patient with hypertrophic cardiomyopathy (HCM) who presented with preexcitation pattern on the surface ECG suggestive of the Wolff-Parkinson-White (WPW) syndrome is described. Intracardiac electrophysiological study revealed a fixed anomalous QRS complex and a short-fixed His-ventricular interval indicating a fasciculoventricular Mahaim fiber. As this specific form of accessory connection does not cause reentrant tachycardias, no treatment was required. It is important to distinguish this entity from atriofascicular or nodoventricular Mahaim fibers or the WPW syndrome in patients with HCM showing a preexcitation pattern in the surface ECG, as these may cause life-threatening arrhythmias in this patient population.

Adult↗
PubMed1995

[High-frequency current ablation of a Mahaim fiber at the tricuspid annulus].

The Mahaim syndrome is a rare variant of accessory pathways. Typically, a normal surface ECG and paroxysmal tachycardias with left bundle branch block morphology are found. The anatomic correlate is an atrioventricular or atriofascicular fiber with decremental conduction properties. Criteria for intracardiac mapping of the atrial insertion of such a fiber include: 1) maximal preexcitation and a short stimulus-QRS interval with differential pacing from the atrial aspect of the tricuspid annulus, and 2) recording of an accessory pathway potential ("M" potential). We report a case of a patient that underwent successful radiofrequency ablation of a Mahaim fiber at the tricuspid annulus.

Bundle-Branch Block↗
PubMed1994

Potential of intracardiac ultrasonography as an adjunct for mapping and ablation.

Radio frequency catheter ablation of cardiac tissues has evolved rapidly as the standard therapy for various arrhythmias. Current mapping techniques include fluoroscopy and endocardial ECG recordings. These techniques are time-consuming and give only limited information with regard to cardiac anatomy and pathology. Moreover, fluoroscopy leads to significant radiation exposure to the patient and the operator. Intracardiac ultrasonography is a promising new technique that may improve intracardiac anatomic orientation, reduce radiation exposure, allow better control of lesion formation during radio frequency current application, and identify possible complications such as thrombus formation or perforation. Intracardiac ultrasonography systems that are presently available are limited by insufficient penetration depth and image resolution. Technical refinements are discussed that may improve the applicability of intracardiac echocardiography for electrophysiologic mapping procedures.

Animals↗
PubMed1993

[New diagnostic methods--ultrasound and clinico-chemical procedures in diagnosis of ischemia].

Stress-echocardiography represents a new non-invasive, alternative approach in the assessment of patients with coronary artery disease. By means of dynamic or pharmacological stress or by atrial pacing regional wall motion abnormalities can be induced, which can be identified by 2D-echocardiography. Beyond the indirect detection of ischemia this approach allows a better quantification of the amount of ischemia and of global LV function, which is advantageous compared to stress ECG recording or myocardial scintigraphy. Disadvantageous is however, the subjective reading of the echo itself. In experienced hands stress-echocardiography has proven to be as sensitive and specific as myocardial scintigraphy. Recently, in addition the diagnostic potential of myocardial cell injury has been improved by the detection of specific antibodies versus Troponin T. In comparison with conventional biochemical markers of myocardial cell necrosis Troponin T analysis has been proven to be superior in postoperative or traumatic cardiac damage or in the setting of acute myocardial infarction. In this situation the time window is improved by an earlier rise compared to CK and a longer detection rate compared to lactate dehydrogenase.

Adenosine↗
PubMed1991

[A iatrogenic arteriovenous fistula following laminectomy. A rare differential diagnosis of heart failure].

An abdominal murmur was first heard in a now 46-year-old man four years after laminectomy at the age of 21. Signs of right heart failure and, ultimately, of global heart failure developed progressively and increasingly 20 years later. Echocardiography demonstrated enlargement of the right heart cavities, and atrial fibrillation was diagnosed. Cardiac catheterization revealed the typical picture of high output failure (cardiac output 13.9 l/min). Intra-arterial subtraction angiography demonstrated a fistula between the left iliac artery and vein. After operative closure of the fistula the signs of heart failure disappeared. Six months later a residual but insignificant fistula was still present, as well as persistent atrial fibrillation. Medical treatment having failed cardioversion successfully re-established sinus rhythm and the patient became symptom-free. Arteriovenous fistula after laminectomy is a rare cause of heart failure and often diagnosed very late. The prognosis is good once the fistula has been closed.

Arteriovenous Fistula↗